相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of the necessity and the feasibility of the standardization of procalcitonin measurements: Activities of IFCC WG-PCT with involvement of all stakeholders
Huu-Hien Huynh et al.
CLINICA CHIMICA ACTA (2021)
Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
Kristina E. Rudd et al.
LANCET (2020)
Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay
Giuseppe Lippi et al.
DIAGNOSTICS (2020)
Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin
Anne Marie Dupuy et al.
DIAGNOSTICS (2020)
Analytical performances of a novel point-of-care procalcitonin assay
Anne Marie Dupuy et al.
PRACTICAL LABORATORY MEDICINE (2020)
Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition
Sun Ju Kim et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
Philipp Schuetz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Evaluation of procalcitonin immunoassay concordance near clinical decision points
Allison B. Chambliss et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
Vincent Delatour et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis
Janne C. Mewes et al.
PLOS ONE (2019)
Evaluation of INSTAND e.V.'s external quality assessment for C-reactive protein and procalcitonin
Nathalie Wojtalewicz et al.
PLOS ONE (2019)
Comparison of Procalcitonin Assays on KRYPTOR and LIAISON® XL Analyzers
Mariella Dipalo et al.
DIAGNOSTICS (2019)
Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect)
Abass Eidizadeh et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis
Meichun Tan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Agreement Between Two Procalcitonin Assays in Hospitalized Children
Sophie E. Katz et al.
INFECTIOUS DISEASES AND THERAPY (2019)
The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review
Aziza N. AlRawahi et al.
CRITICAL CARE (2019)
Comparison of the Abbott Architect BRAHMS and the Biomerieux Vidas BRAHMS Procalcitonin Assays
Dan Wang et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations
Valentinas Gruzdys et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer
Ahmed El Mouatani et al.
ANNALES DE BIOLOGIE CLINIQUE (2018)
Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems
A. Soh et al.
PRACTICAL LABORATORY MEDICINE (2018)
Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor
Ferruccio Ceriotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis
Philipp Schuetz et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Recognizing Sepsis as a Global Health Priority - A WHO Resolution
Konrad Reinhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
Christopher W. Seymour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study
Ramon Sager et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
Ashitha L. Vijayan et al.
JOURNAL OF INTENSIVE CARE (2017)
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
Philipp Schuetz et al.
CRITICAL CARE MEDICINE (2017)
Procalcitonin-guided diagnosis and antibiotic stewardship revisited
Ramon Sager et al.
BMC MEDICINE (2017)
Current practices and challenges in the standardization and harmonization of clinical laboratory tests
Hubert W. Vesper et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Evelien de Jong et al.
LANCET INFECTIOUS DISEASES (2016)
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial
Frank Bloos et al.
JAMA INTERNAL MEDICINE (2016)
The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis
Luis Cabral et al.
PLOS ONE (2016)
Global Epidemiology of Pediatric Severe Sepsis: The Sepsis Prevalence, Outcomes, and Therapies Study
Scott L. Weiss et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: A meta-analysis
Haitao Ren et al.
BURNS (2015)
Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800
Mariella Dipalo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
Philipp Schuetz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis
Dan Liu et al.
PLOS ONE (2015)
Diagnostic and prognostic markers in sepsis
Jean-Louis Vincent et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture
Seri Jeong et al.
CLINICA CHIMICA ACTA (2012)
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis
Evridiki K. Vouloumanou et al.
INTENSIVE CARE MEDICINE (2011)
Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays
Philipp Schuetz et al.
CLINICAL BIOCHEMISTRY (2010)
Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
Pierre Hausfater et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Effect of early achievement of physiologic resuscitation goals in septic patients admitted from the ward on the kidneys
N. D. Kiers et al.
JOURNAL OF CRITICAL CARE (2010)
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Lila Bouadma et al.
LANCET (2010)
Lack of Transferability of Results between Procalcitonin Assays
Belen Prieto et al.
CLINICAL CHEMISTRY (2009)
Comparison of a New Procalcitonin Assay from Roche with the Established Method on the Brahms Kryptor
Holger K. de Wolf et al.
CLINICAL CHEMISTRY (2009)
Evaluation of two automated immunoassays for procalcitonin measurement: Kryptor® (Brahms) and Vidas® (BioMerieux)
J. -F. Lagabrielle et al.
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE (2008)
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain
Ricard Ferrer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Agreement between methods
Karlijn J. van Stralen et al.
KIDNEY INTERNATIONAL (2008)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients
GA Wanner et al.
CRITICAL CARE MEDICINE (2000)
分享论文
